Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/30082
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKumar, Sunil-
dc.contributor.authorKaur, Hemlata-
dc.contributor.authorSaxena, K K-
dc.contributor.authorYeshowardhana-
dc.date.accessioned2014-12-24T07:41:27Z-
dc.date.available2014-12-24T07:41:27Z-
dc.date.issued2014-12-
dc.identifier.issn0975-0983(Online); 0376-4699(Print)-
dc.identifier.urihttp://hdl.handle.net/123456789/30082-
dc.description1596-1605en_US
dc.description.abstract2-Methyl/ethyl-5-methoxy/ethoxy-3-(2-benzofuran-2-yl)-3-((2-substitutedphenylazo) pyrazolin-4-yl)indoles 3a-l have been prepared by the reaction of 2-methyl/ethyl-5-methoxy/ethoxy-3-((2-benzofuran-2-yl)-pyrazolin-4-yl)indoles 2a-d with various substituted benzenediazonium chlorides in presence of sodium acetate. Compounds 3a-l on reaction with different 4-aminopyridine and formaldehyde yield 2-methyl/ethyl-5-methoxy/ethoxy-3-((2-benzofuran-2-yl)-1-(pyridinylamino)methyl-3-substitutedphenylazo)-pyrazolin-4-yl)indoles 4a-l. All the newly synthesized compounds 3a-l and 4a-l have been screened for their antiparkinsonian activity. Structures of all the compounds are established by elemental and spectral (IR, 1H NMR and mass spectroscopic) analysis.en_US
dc.language.isoen_USen_US
dc.publisherNISCAIR-CSIR, Indiaen_US
dc.rights CC Attribution-Noncommercial-No Derivative Works 2.5 Indiaen_US
dc.sourceIJC-B Vol.53B(12) December 2014]en_US
dc.subjectIndolesen_US
dc.subjectPyrazolinylindolesen_US
dc.subjectPyrazolinylpyridinylindolesen_US
dc.subjectAntiparkinsonian activityen_US
dc.subjectAcute toxicityen_US
dc.titleSynthesis and antiparkinsonian activity of different pyrazolinylpyridinyl indole derivativesen_US
dc.typeArticleen_US
Appears in Collections:IJC-B Vol.53B(12) December 2014]

Files in This Item:
File Description SizeFormat 
IJCB 53B(12) 1596-1605.pdf128.82 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.